Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K991369
    Date Cleared
    1999-05-10

    (20 days)

    Product Code
    Regulation Number
    862.1155
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    ACCUDIP HOME PREGNANCY AND/OR AIMSTICK PREGNANCY

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    AccuDip™ Home Pregnancy and/or AimStick™ Pregnancy is intended for non-professional over-the-counter use for the qualitative identification of hCG (human Chorionic Gonadotropin) in urine to aid in the determination of pregnancy.

    Device Description

    The test utilizes a combination of monoclonal antibody reagents to selectively detect elevated levels of hCG. The assay is conducted by dipping the absorbent wick of the test in urine and observing for the formation of colored liness. The specimen migrates via capillary action along the wick and membrane to react with the colored conjugate. Positive specific antibody-hCG-colored conjugate and form a colored line on the Specimen portion of the membrane. Absence of this colored line suggests a negative result. To serve as a procedural control, a colored line at the Control Zone will always appear regardless of the presence or absence of hCG.

    AI/ML Overview

    Here's an analysis of the provided text regarding the AccuDip™ Home Pregnancy Test, formatted to address your specific questions:

    AccuDip™ Home Pregnancy Test Study Analysis

    1. Table of Acceptance Criteria and Reported Device Performance

    Acceptance CriteriaReported Device Performance
    Detects hCG concentrations of 20 mIU/ml and greater."The AccuDip™ Home Pregnancy test detects hCG concentrations of 20 mIU/ml and greater."
    No cross-reactivity with hLH (300 mIU/ml), hFSH (1000 mIU/ml), and hTSH (1000 µIU/ml) in negative (0 mIU/ml hCG) and positive (20 mIU/ml hCG) urine."The addition of hLH (300 mIU/ml), hFSH (1000 mIU/ml), and hTSH (1000 µIU/ml) to negative (0 mIU/ml hCG) and positive (20 mIU/ml hCG) urine showed no cross-reactivity."
    Ease of use for non-professional users."The majority of the participants found AccuDip™ Home Pregnancy and/or AimStick™ Pregnancy very easy to use."
    Understandability of labeling and instructions for non-professional users."They had no trouble understanding the labeling, reading the instructions..."
    Interpretability of results for non-professional users."...or interpreting the results."
    Overall suitability for over-the-counter pregnancy testing."The overall results of the clinical trial confirm that AccuDip™ Home Pregnancy and/or AimStick™ Pregnancy is a suitable test for over-the-counter pregnancy testing."

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size for Test Set: 73 female participants.
    • Data Provenance: The document does not specify the country of origin. It can be inferred to be a prospective clinical trial given the description of "clinical trials using AccuDip™ Home Pregnancy and/or AimStick™ Pregnancy were conducted which included 73 female participants."

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

    The document does not provide information on the number of experts or their qualifications used to establish the ground truth for the test set. It describes a "clinical trial" but does not detail how pregnancy status (ground truth) was definitively determined for the 73 participants.

    4. Adjudication Method (for the test set)

    The document does not specify any adjudication method for establishing the ground truth of the test set.

    5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done

    No, an MRMC comparative effectiveness study was not done. This device is an in-vitro diagnostic test for self-use, not a medical imaging or diagnostic interpretation system designed for human readers.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done

    Yes, the primary "performance" described pertains to the standalone device's ability to detect hCG and its analytical specificity, as well as user comprehension. The test itself is designed for standalone use by consumers.

    7. The Type of Ground Truth Used

    The document broadly refers to "clinical trials" and the "determination of pregnancy." For the analytical performance (hCG detection and cross-reactivity), it implies:

    • Known hCG concentrations: For the "detection of hCG concentrations of 20 mIU/ml and greater." This would likely involve spiked samples or serially diluted known positive samples.
    • Known concentrations of interferents: For the cross-reactivity study with hLH, hFSH, and hTSH, likely using samples with known concentrations of these hormones and known hCG status (0 mIU/ml or 20 mIU/ml).
    • For the user study with 73 participants, the ground truth for "pregnancy status" is not explicitly stated but would ideally be confirmed by a gold standard method (e.g., laboratory quantitative hCG test) a short time after the home test. The focus of this part of the study seems to be on user comprehension and ease of use, not necessarily the diagnostic accuracy of the device against a clinical gold standard performed at the same time.

    8. The Sample Size for the Training Set

    The document does not mention a training set sample size. This type of diagnostic device (lateral flow immunoassay) typically does not involve machine learning or AI models with distinct "training" and "test" sets in the way that software algorithms do. The development and validation process focuses on analytical performance and clinical evaluation.

    9. How the Ground Truth for the Training Set Was Established

    As there is no mention of a training set in the context of machine learning, this question is not applicable. The ground truth for the analytical and clinical studies described in the summary would have been established through laboratory controls (known concentrations) and, presumably, standard clinical methods for pregnancy determination.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1